Search
Support us
  • RESEARCH
  • PUBLICATIONS
  • IMMUNOGENICITY AFTER SECOND AND THIRD MRNA-1273 VACCINATION DOSES IN PATIENTS RECEIVING CHEMOTHERAPY, IMMUNOTHERAPY, OR BOTH FOR SOLID TUMOURS.

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours.

  • Show more authors
    + 19
  • Sjoukje F Oosting
  • Astrid A M van der Veldt
  • Rudolf S N Fehrmann
  • Corine H GeurtsvanKessel
  • Rob S van Binnendijk
  • Anne-Marie C Dingemans
  • Egbert F Smit
  • T Jeroen N Hiltermann
  • Gerco den Hartog
  • Mathilda Jalving
  • Tatjana T Westphal
  • Arkajyoti Bhattacharya
  • Faye de Wilt
  • Annemarie Boerma
  • Lisanne van Zijl
  • Guus F Rimmelzwaan
  • Pia Kvistborg
  • Cecile A C M van Els
  • Nynke Y Rots
  • Debbie van Baarle
  • John B A G Haanen
  • Elisabeth G E de Vries

More about this publication

The Lancet. Oncology
  • Volume 23
  • Issue nr. 7
  • Pages 833-835
  • Publication date 01-07-2022
Full text links

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.